Artificial Intelligence in the Service of Medicine: Current Solutions and Future Perspectives, Opportunities, and Challenges.

Q2 Medicine

Clinica Terapeutica Pub Date : 2025-03-01 DOI:10.7417/CT.2025.5192

S Marinelli, L De Paola, M Stark, G Montanari Vergallo

{"title":"Artificial Intelligence in the Service of Medicine: Current Solutions and Future Perspectives, Opportunities, and Challenges.","authors":"S Marinelli, L De Paola, M Stark, G Montanari Vergallo","doi":"10.7417/CT.2025.5192","DOIUrl":null,"url":null,"abstract":"Objective: This article aims to identify the opportunities and risks of Artificial Intelligence tools (AIT) applied to clinical practice, while also reflecting on their impact on the doctor-patient relationship.Materials and methods: The authors conducted a systematic literature review following the PRISMA guidelines, selecting the period from 2019 to October 2024. Academic databases PubMed and Scopus were drawn upon by using the keywords and searchstrings \"artificial intelligence\", \"healthcare\", \"informed consent\", and \"doctor-patient relationship\" in titles, abstracts, and keywords.Results and discussion: AIT has proven useful in significantly reducing the time spent on bureaucratic tasks and minimizing errors compared to traditional medicine. However, their effectiveness is highly influenced by the quantity and quality of data used for training. Additionally, there is an issue with the transparency of the decision-making process because AIT and even their programmers are unable to explain their diagnostic and therapeutic recommendations. Therefore, human supervision of AI work is essential.Conclusions: The potential risks of AI for patient safety and personal data security necessitate that governments urge those involved in the production of AI tools to adhere to specific ethical standards developed with the participation of all stakeholders, including patients.","PeriodicalId":50686,"journal":{"name":"Clinica Terapeutica","volume":"176 Suppl 1(2)","pages":"77-82"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Terapeutica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7417/CT.2025.5192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: This article aims to identify the opportunities and risks of Artificial Intelligence tools (AIT) applied to clinical practice, while also reflecting on their impact on the doctor-patient relationship.

Materials and methods: The authors conducted a systematic literature review following the PRISMA guidelines, selecting the period from 2019 to October 2024. Academic databases PubMed and Scopus were drawn upon by using the keywords and searchstrings "artificial intelligence", "healthcare", "informed consent", and "doctor-patient relationship" in titles, abstracts, and keywords.

Results and discussion: AIT has proven useful in significantly reducing the time spent on bureaucratic tasks and minimizing errors compared to traditional medicine. However, their effectiveness is highly influenced by the quantity and quality of data used for training. Additionally, there is an issue with the transparency of the decision-making process because AIT and even their programmers are unable to explain their diagnostic and therapeutic recommendations. Therefore, human supervision of AI work is essential.

Conclusions: The potential risks of AI for patient safety and personal data security necessitate that governments urge those involved in the production of AI tools to adhere to specific ethical standards developed with the participation of all stakeholders, including patients.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinica Terapeutica PHARMACOLOGY & PHARMACY-

CiteScore

2.50

自引率

0.00%

发文量

124

审稿时长

6-12 weeks

期刊介绍： La Clinica Terapeutica è una rivista di Clinica e Terapia in Medicina e Chirurgia, fondata nel 1951 dal Prof. Mariano Messini (1901-1980), Direttore dell''Istituto di Idrologia Medica dell''Università di Roma “La Sapienza”. La rivista è pubblicata come “periodico bimestrale” dalla Società Editrice Universo, casa editrice fondata nel 1945 dal Comm. Luigi Pellino. La Clinica Terapeutica è indicizzata su MEDLINE, INDEX MEDICUS, EMBASE/Excerpta Medica.